Cancer combo trial pulled before it even started

NCT ID NCT06084689

Terminated Disease control Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study was designed to test a combination of two drugs, Ezabenlimab and BI907828, in people with advanced solid tumors like sarcoma, lung cancer, and breast cancer. The goal was to see if the treatment could control the disease for at least 24 weeks. However, the trial was withdrawn before enrolling any participants, so no data or conclusions are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Ezabenlimab and BI907828

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

biliary tract cancer Biliary Tract Neoplasms colorectal cancer colorectal neoplasm non-small cell lung carcinoma sarcoma soft tissue sarcoma Tertiary Lymphoid Structures triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ADULT SOFT TISSUE SARCOMA BILIARY TRACT CANCER COLORECTAL CANCER NON-SMALL-CELL LUNG CANCER TRIPLE NEGATIVE BREAST CANCER

Contacts and locations

Show contact details

Locations

CHRU Poitiers

Poitiers, France
Centre Eugène Marquis

Rennes, France
Centre Georges François Leclerc

Dijon, France
Centre Léon Bérard

Lyon, France
Centre Oscar Lambret

Lille, 59000, France
Institut Bergonié

Bordeaux, 33076, France